To evaluate if factors, such as HMGB1 that are released from keratinocytes with elevated polyamine biosynthesis, can differentially affect tumorsphere formation by As-HaCaT cells, we tested the effect of secreted factors from Ker/Norm and Ker/ODC cultures on As-HaCaT and parental HaCaT tumorsphere formation. MT-4 expression of Toll-Like Receptor 4 (TLR4), CD34 and CXCR4 as did As-HaCaT tumorsphere cultures compared to As-HaCaT monolayer cultures. Ornithine decarboxylase (ODC) overexpressing keratinocytes (Ker/ODC) release increased levels of the alarmin high mobility group box 1 (HMGB1). Ker/ODC conditioned medium (CM) stimulated As-HaCaT but not parental HaCaT tumorsphere formation, and this was MT-4 inhibited by glycyrrhizin, an inhibitor of HMGB1, and by TAK242, an inhibitor of the HMGB1 receptor TLR4. Compared to parental HaCaT cells, As-HaCaT cells demonstrated greater invasiveness across a Matrigel-coated filter using either fibroblast CM or SDF-1 as chemoattractants. Addition of Ker/ODC CM or HMGB1 dramatically increased As-HaCaT invasiveness. Glycyrrhizin and TAK242 inhibited this Ker/ODC CM-stimulated invasion of As-HaCaT cells but not HaCaT cells. These results show that polyamine-dependent release of HMGB1 promotes the expansion of stem cell-like subpopulations in arsenic-transformed keratinocytes while also increasing their invasiveness, suggesting that polyamines may be a potential therapeutic target for the prevention and treatment of arsenic-initiated skin cancers. Introduction environmental exposure to naturally occurring arsenic in the drinking water poses a daunting global health issue, with approximately 150 million people exposed to toxic levels of arsenic (1,2). High concentrations of arsenic in underground water are also found in many parts of the United States. Arsenic is the most common worldwide contaminant in soil, groundwater, food and plants (2). Chronic exposure to arsenic in humans is causally associated with neoplasias of the skin and to a lesser extent, of the lung, liver, kidney and bladder. Epidemiological studies suggest that the population cancer risk from arsenic in water supplies in the United States may be comparable to that of environmental tobacco smoke and radon in homes with risk estimates of approximately 1 in 1000 (3). However, the mechanisms contributing to arsenic-induced cancer are complex and elusive, largely due to the lack of predictive animal models. The difficulty in inducing tumors in adult rodents following arsenic exposure as a single agent reflects that it often takes 10- to 100-fold higher doses of arsenic to manifest toxic effects in animals compared to that in humans (4). Most animal investigations of arsenic-induced carcinogenesis have included the co-administration of another carcinogen, UV irradiation or the presence of an activated oncogene (5). Accumulating evidence suggests that arsenic is a transplacental carcinogen in both animals (6C8) and humans (9,10), and that it targets fetal stem cells leading to dysregulation of the normally tightly regulated process MT-4 of stem cell self-renewal and differentiation (7,8). In addition, arsenic-induced transformation of human keratinocytes has been reported to lead to increased numbers of putative cancer stem cells (6). These observations suggest that arsenic targets and dysregulates stem cell populations that remain dormant in the skin until promoted (by TPA or wounding) to be recruited out of the bulge stem cell region, thus giving rise to skin tumors (7). Because carcinogen target cells are thought to be long lived, slowly cycling stem cells found in the hair follicle bulge IgG2a Isotype Control antibody region, it is essential to understand pathways that regulate stem cell recruitment in arsenic-induced skin carcinogenesis. Using Cre recombinase-reporter mice, we have previously reported that elevated levels of polyamines stimulate the recruitment of bulge stem cells in quiescent skin (11). The MT-4 polyamines putrescine, spermidine and spermine are some of the major cations present in all cells. Polyamines have long been known to be MT-4 associated with cell proliferation in normal tissues, and polyamine levels are dramatically elevated in tumors (12). Polyamines are primarily bound to polyanionic macromolecules, particularly RNA, resulting in far-reaching effects upon cellular processes including DNA replication, transcription, and translation. A hallmark of tumor promoting activity involves the induction of ornithine decarboxylase (ODC), the initial rate-limiting enzyme in polyamine biosynthesis. Use of ODC transgenic mouse models has demonstrated that increased ODC activity is sufficient to promote tumor development following a single.